Skip to content

Transcutaneous auricular electrical acupoint stimulation for short-term efficacy evaluation of pulmonary function in perioperative period of thoracoscopic lobect

Scheme for the short-term efficacy evaluation of transcutaneous acupoint electrical stimulation on pulmonary function in the perioperative period of thoracoscopicectomy for lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001331
Enrollment
Unknown
Registered
2025-07-03
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative pulmonary function of lobectomy

Interventions

Sponsors

Henan Provincial Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1)Patients who have been diagnosed with diseases that are suitable for video-assisted thoracoscopic lobectomy including but not limited to lung cancerchiectasis benign lung tumors etc.;2)Aged 18-75 years old;3)Surgical method: received video-assisted thoracoscopicectomy;4)Language ability: patients were able to understand and cooperate with the instructions of the researchers;5)Lung function assessment: preoperative pulmonary function tests showed that the had a certain lung function reserve (such as FEV1 > 1.0 L or more than 40% of the predicted value).

Exclusion criteria

Exclusion criteria: 1) Severe cardiopulmonary insufficiency: such as severe heart failure severe chronic obstructive pulmonary disease (COPD) etc;2) Coagulation dysfunction: such as hemophilia severe thrombocytopenia etc.;3) Mental illness or cognitive impairment: such as severe depression schizophrenia dementia etc.;4) Allergy or contraindication to electrostimulation therapy: such as patients with cardiac pacemakers implantable defibrillators etc;5) Participating in other clinical trials: patients who are participating in other clinical trials may lead to confounding results;6) Unable to cooperate with treatment or follow-up: patients are unable or unwilling to cooperate with the treatment plan or follow-up plan.

Design outcomes

Primary

MeasureTime frame
Inspiratory Capacity(IC);Forced Vital Capacity(FVC);First Expiratory Volume in One Second(FEV1);

Secondary

MeasureTime frame
Borg Dyspnea Rating Scale scoring;Diaphragmatic mobility;Superoxide Dismutase;Malondialdehyde;

Countries

China

Contacts

Public ContactChenxiao Tang

Henan Provincial Third People's Hospital

75748504@qq.com18768877843

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026